Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 14, Issue SUPPL. 1, 2000, Pages

  De la Torre, Jack C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Alzheimer disease; Brain capillary; Cerebral hypoperfusion; Energy metabolism; Glucose; Pathogenesis; Vascular risk factor

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE;

AGING; ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN CAPILLARY; BRAIN PERFUSION; COGNITIVE DEFECT; CONFERENCE PAPER; GLYCOLYSIS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PRIORITY JOURNAL; SENILE PLAQUE; SIGNAL TRANSDUCTION;

AGING; ALZHEIMER DISEASE; BRAIN; BRAIN ISCHEMIA; CAPILLARIES; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; ENERGY METABOLISM; GLUCOSE; HUMANS; RISK FACTORS;

EID: 0034042913     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200000001-00012     Document Type: Conference Paper

References (95)

1. Ajmani RS, Rifkind JM. Hemorheological changes during human aging. Gerontology 1998;44:111-20.
2. Arriagada PV, Growdon JH, Hedley-White ET, Hyman B. Neurofibrillar tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-9.
3. Blass JP. Pathophysiology of the Alzheimer's syndrome. Neurology 1993;(suppl 4):S25-38.
4. Bobinski M. Neuronal volume and loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer's disease. Brain Res 1998;805:267-9.
5. Braak H, Braak E, Age, neurofibrillary changes, A-beta and onset of Alzheimer's disease. Neurosci Lett 1996;210:87-90.
6. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997;4:351-7.
7. Breitner JCS. Vascular compromise promotes Alzheimer's disease. Neurobiol Aging 1998;19(4S):S220.
8. Breleler MMB. Epidemiological evidence of a connection between Alzheimer's disease and vascular dementia. Neurobiol Aging 1998; 19(4S):S150.
9. Breteler MMB, Bots ML, Ott A, Hofman A. Risk factors for vascular disease and dementia. Haemostasis 1998;28:167-73.
10. Buée L, Hof PR, Bouras C, et al. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related demented disorders. Acta Neuropathol 1994;87:469-80.
11. Caamano J, Gomez MJ, Franco-Masides M, Cacabelos R. Effects of CDP-choline on cognition and cerebral hemodynamics in Alzheimer's disease. Methods Find Exp Clin Pharmacol 1994;16:211-8.
12. Celsis P, Agniel A, Cardebat D, Demonet JF, Ousset P, Puel M. Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance. J Neurol Neurosurg Psychiatr 1997;62:601-8.
13. Chemtob S, Beharry K, Barna T, Varma BR, Aranda JV. Differences in the effects of newborn piglet of various non-steroidal anti-inflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Ped Res 1991;30:106-111.
14. Chen Y, Weii S, Mourelatos Z, Gonatas J, Okamoto K, Gonatas NK. The fragmented neuronal Golgi apparatus in ALS includes the trans-Golgi network: functional implications. Acta Neuropathol 1998;95: 245-53.
15. Claus JJ, Breteler MM, Hasan D. Regional cerebral blood flow and cerebrovascular risk factors in the elderly population. Neurobiol Aging 1998;19:57-64.
16. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 1999;58:376-88.
17. DeCarli C. Post-mortem regional neurofibrillary tangle densities, but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer disease patients. Neurodegeneration 1992;1:11-20.
18. de Jong GI, Farkas E, Plass J, Keijser JN, de la Torre JC, Luiten PGM. Cerebral hypoperfusion yields capillary damage in hippocampus CA1 that correlates to spatial memory impairment. Neuroscience 1999;91:203-10.
19. de la Torre JC. Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging. Gerontology 1997a;43:26-43.
20. de la Torre JC. Critically-attained threshold of cerebral hypoperfusion: The CATCH hypothesis of Alzheimer's pathogenesis. Neurobiol Aging. In press.
21. de la Torre JC. Critical threshold cerebral hypoperfusion causes Alzheimer's disease. Acta Neuropathol 1999;98:1-8.
22. de la Torre JC, ed. Vascular pathophysiology in Alzheimer's disease. Neurobiol Aging 2000;21.
23. de la Torre JC, Fortin T, Saunders J. Correlates between NMR spectroscopy, diffusion weighted imaging and CA1 morphometry following chronic brain ischemia. J Neurol Sci Res 1995;41:238-45.
24. de la Torre JC, Hachinski V, eds. Cerebrovascular pathology in Alzheimer's disease. Ann N Y Acad Sci 1997;826:1-519.
25. de la Torre JC. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease. Ann N Y Acad Sci 1997b;826: 75-91.
26. de la Torre JC. Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci Behav Rev 1994;18:397-401.
27. de la Torre JC, Mussivand T. Can disturbed brain microcirculation cause Alzheimer's disease? Neurol Res 1993;15:146-53.
28. Duara R, Barker WW, Chang J, Yoshii F. Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer's disease. J Cereb Blood Flow Metab 1992;12:927-34.
29. Englund E. Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 1998; 9(suppl 1):6-12.
30. Erecinska M, Silver I. ATP and brain function. J Cereb Blood Flow Metab 1989;9:2-12.
31. Erkinjuntti T, Benavente O, Eliasziw M, et al. Diffuse vacuolization (spongiosis) and arteriosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol 1996;53:325-32.
32. Fioravanti M, Ricciardi T, Solerte SB. Hemorheologic alterations and acute-phase reaction are related to recent-onset patients with senile dementia of the Alzheimer's type. Neurobiol Aging 1998;19(4S): S246-7.
33. Frangione B. Familial cerebral amyloid angiopathies and dementia. Alzheimer Dis Assoc Disord 2000;14(suppl 1):S25-30.
34. Gold G, Giannakopulos P, Bouras C. Reevaluating the role of vascular changes in the differential diagnosis of Alzheimer's disease and vascular dementia. Eur Neurol 1998;40:121-9.
35. Goldsmith HS. Role of the omentum in the treatment of Alzheimer's disease. In: Goldsmith HS, ed. The omentum: application to brain and spinal cord. Wilton, CT: Forefront Publishing, 2000:184-97.
36. Guo Z, Viitanen M, Fratiglioni L, Winblad B. Blood pressure and dementia in the elderly: epidemiologic perspectives. Biomed Pharmacother 1997;51:68-73.
37. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997;4:154-9.
38. Hatanpäa K, Brady DR, Stoll J, Rapoport SI. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1996;40:411-20.
39. Hatanpäa K, Chandrasekaran K, Brady DR, Rapoport SI. No association between Alzheimer plaques and decreased levels of cytochrome oxidase unit mRNA, a marker of neuronal energy metabolism. Brain Res Mol Brain Res 1998;59:13-21.
40. Hofman A, Ott A, Breteler M, Bots M, Slooter A, Grobbee D. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997;349:151-4.
41. Hofman A. Vascular factors and Alzheimer's disease: epidemiologic evidence for a causal connection. Neurobiol Aging 1998;19(4S): S220.
42. Hoyer S. Senile dementia and Alzheimer's disease, brain blood flow and metabolism. Prog Neuropsychopharmacol Biol Psychiatry 1986;10:447-78.
43. Hsiao K, Chapman P, Nilsen S. Correlative memory deficits, A-beta elevation, and amyloid plaques in transgenic mice. Science 1996; 274:99-102.
44. Iadecola C, Zhang F, Niwa K. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nature Neurosci 1999;2:157-61.
45. Ihara Y, Chuda M, Kuroda S. Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia. J Neurol Sci 1997;153:76-81.
46. Jellinger KA. Vascular dementia: disease entity or Alzheimer lesion? Neurohiol Aging 1998;19(4S):S219.
47. Ji Y, Urakami K, Adachi Y, Maeda M, Isoe K, Nakashima K. Apolipoprotein E polymorphism in patients with Alzheimer's disease. vascular dementia and ischemic cerebrovascular disease. Dement Geriatr Cogn Disord 1998;5:243-5.
48. Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563-71.
49. Kalaria RN, Harik SE. Reduced glucose transporter at the blood-brain barrier and in the cerebral cortex in Alzheimer's disease. J Neurochem 1989;53:1083-8.
50. Kalaria RN, Hedera P. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuro Report 1995;6:477-80.
51. Kalaria RN, Ince PG, eds. Vascular factors in Alzheimer's disease. Ann N Y Acad Sci 2000;903:1-600.
52. Kalmijn S, Launer LJ, Ott A. Dietary fat intake and risk of incident dementia in the Rotterdam study. Ann Neurol 1997;42:776-82.
53. Katzman R, Aronson M, Fuld P. Development of dementing illness in an 80-year old cohort. Ann Neurol 1989;25:317-24.
54. Khachaturian ZS. Plundered memories. The Sciences 1997;July-August:21-5.
55. Kittner B, Rossner M, Rother M. Clinical trials in dementia with propentofylline. Ann N Y Acad Sci 1997;826:307-16.
56. Kristian T, Siesjo BK. Calcium in ischemic cell death. Stroke 1998; 29:705-18.
57. Kumar V, Calache M. Treatment of Alzheimer's disease with cholinergic drugs. Int J Clin Pharmacol Ther Toxicol 1991;29:23-37.
58. Lechner H. Status of treatment of vascular dementia. Neuroepidemiology 1998;17:10-3.
59. Lehmann M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement Geriatr Cogn Dis 1999;10:12-20.
60. Leibson CL, Rocca WA, Hanson V, Cha R. The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann N Y Acad Sci 1997;826:422-7.
61. Luiten PGM, de Jong GI, Farkas E, Plass J, De Vos R, Jansen EN. Cerebral microvascular breakdown in dementias and after experimental cerebral hypoperfusion. Neurobiol Aging 1998;19(4S):S290.
62. Mancardi GL, Perdelli F, Leonardi A, Bugiani O. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease. Acta Neuropathol 1980;49:79-83.
63. Mann DMA, Neary D, Testa H. Adult dementias. London: Mosby-Wolf, 1994:23-70.
64. Martin AJ, Friston KJ, Colebatch JG, Frackowiak R. Decreases in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab 1991;1:684-9.
65. Mattila KM, Dirttila T, Blennow K. Altered blood-brain barrier function in Alzheimer's disease? Acta Neurol Scand 1994;89:192-8.
66. Mattson MP. Central role of oxyradicals in the mechanism of amyloid β-peptide cytotoxicity. Alzheimer's Dis Rev 1997;2:1-14.
67. Meier-Ruge W, Bertoni-Freddari C. The significance of glucose turnover in the brain in the pathogenic mechanisms of Alzheimer's disease. Rev Nearosci 1996;7:1-19.
68. Meyer JS, Terayama Y, Konno S, Akiyama H. Risk factors for cerebral degenerative changes and dementia. Eur Neurol 1998;39(suppl 1): 7-16.
69. Miyakawa T. Electron microscopy of amyloid fibrils and microvessels. Ann N Y Acad Sci 1997;826:25-34.
70. Moody DM, Brown WR, Venkata R. Cerebral microvascular alterations in aging, leukoaraiosis and Alzheimer's disease. Ann N Y Acad Sci 1997;826:103-16.
71. Nagata K, Buchan RJ, Yokoyama E, Kondoh Y, Sato M. Misery perfusion with preserved vascular reactivity in Alzheimer's disease. Ann N Y Acad Sci 1997;826:272-81.
72. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocrine J 1994;41:361-71.
73. Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study. The Rotterdam Study. Lancet 1998;39:198-202.
74. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia. The Rotterdam Study. Diabetologica 1996;39:1392-7.
75. Parnetti L, Mar D, Mecocci P, Senin U. Pathogenic mechanisms in vascular dementia. Int J Clin Lab Res 1994;24:15-22.
76. Pasquier F, Leys D, Scheltens P. Why are stroke patients prone to develop dementia? J Neurol 1997;244:135-42.
77. Perlmutter LS, Myers, MA, Barron E. Vascular basement membrane components and the lesions of Alzheimer's disease. Micros Res Tech 1994;28:204-15.
78. Resnick SM, Maki PM, Golski S, Kraut M, Zonderman A. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Harm Behav 1998;34:171-82.
79. erk converts tau into PHF-like form as found in Alzheimer's disease. Biochem Biophys Res Comm 1993;193:639-47.
80. Salehi A, Swaab D. Relationship between neuronal activity, neuropathological hallmarks and genetic background in Alzheimer's disease. Neurobiot Aging 1998;19(4S):S5.
81. Scheibel AB, Duong T, Tomiyasu O. Microvascular changes in Alzheimer's disease. In: Scheibel AB, Wechsler AF, Brazier MAB, eds. The biological substrates of Alzheimer's disease. New York: Academic Press, 1986:77-192.
82. Skoog I, Andreasson L, Landahl S. A population study on blood-brain barrier function in 85-year olds: relation to Alzheimer's disease and vascular dementia. Neurology 1998;50:966-71.
83. Skoog I. The interaction between vascular disorders and Alzheimer's disease. In: Iqbal K, Swaab B, Winblad B, Wiesnewski H, eds. Alzheimer's disease and related disorders. New York: Wiley & Sons, 1998:523-30.
84. Skoog I. The relationship between blood pressure and dementia: a review. Biomed Pharmacother 1997;51:367-75.
85. Sparks DL. Coronary artery disease, hypertension. ApoE and cholesterol: a link to Alzheimer's disease? Ann N Y Acad Sci 1997;826: 128-46.
86. Stieber A, Mourelatos Z, Gonatas NK. In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic. Am J Path 1996;148:415-26.
87. Sulkava R, Erkinjuntti T, Palo J. Head injuries in Alzheimer's disease and vascular dementia. Neurology 1984;35:1804.
88. Sulkava R, Erkinjuntti T. Vascular dementia due to cardiac arrythmias and systemic hypotension. Acta Neurol Scand 1987;76:123-8.
89. Suo Z, Humphrey J, Kundtz A, Sethi F, Crawford F, Mullan M. Soluble Alzheimer's β-amyloid constricts the cerebral vasculature in vivo. Neurosci Lett 1998;257:77-80.
90. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-80.
91. Tohgi H, Yonezawa H, Takahashi S, Sato N. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology 1998;40:131-7.
92. van Kooten F, Bots ML, Breteler MM. The Dutch vascular factors in dementia study: rationale and design. J Neurol 1998;245:32-9.
93. Volterra A, Trotti D, Tromba C, Floridi S, Racagni G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosci 1994;14:2924-32.
94. Waldemar G, Hogh P, Paulson OB. Functional brain imaging with single-photon emission computed tomography in the diagnosis of Alzheimer's disease. Int Psychogeriatr 1997;9(suppl 1):223-7.
95. Xie Y, Mies G, Hossmann KA. Ischemic threshold of brain protein synthesis after unilateral carotid occlusion in gerbils. Stroke 1989; 20:620-6.